Insider and congress filings

Pfizer Inc. (PFE)

NYSE · Healthcare · 390 insider filings · 286 congress trades · last filed 10 days agoS&P 500

5
Open-market insider filings shown
0d
Median delay on the insider filings
within the two business day rule
3/2
Purchases and sales in the filings shown

About Pfizer Inc.

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - General
Chief executive
Albert Bourla
Employees
75,000
Listed since
-
Market value
$158.3B
Price to earnings
36.7
Earnings per share
$0.76
Dividend yield
6.19%

www.pfizer.com

Earnings

6 reported quarters · next on Nov 3, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 4, 2026$0.77$0.68$15.0B$14.4BEPS beatRevenue beat
Q1 FY2026reported May 5, 2026$0.75$0.72$14.5B$13.8BEPS beatRevenue beat
Feb 3, 2026$0.66$0.57$17.6B$16.8BEPS beatRevenue beat
Q3 FY2025reported Nov 4, 2025$0.87$0.63$16.7B$16.5BEPS beatRevenue in line
Q2 FY2025reported Aug 5, 2025$0.78$0.58$14.7B$13.6BEPS beatRevenue beat
Q1 FY2025reported Apr 29, 2025$0.92$0.67$13.7B$13.9BEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Mar 12, 2026
ExecutiveSalaryStock awardsOtherTotal
A. BourlaChairman and Chief Executive Officer$1.8M$9.4M$16.3M$27.6M
C. BoshoffChief Scientific Officer and President, Research & Dev$1.4M$1.8M$6.8M$10.0M
D. DentonChief Financial Officer, EVP$1.4M$2.4M$5.9M$9.7M
A. MalikChief U.S. Commercial Officer, EVP$1.4M$2.3M$5.8M$9.4M
D. LanklerChief Legal Officer, EVP$1.4M$2.0M$5.7M$9.1M

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$12.8B529,670,433+6.3%9.29%
Vanguard Capital Management LLC$9.0B372,149,852+0.7%6.53%
State Street Corp$7.4B307,090,897+1.8%5.39%
Geode Capital Management, LLC$3.2B135,275,782+1.3%2.37%
Vanguard Portfolio Management LLC$2.9B119,235,030+2.1%2.09%
Fisher Asset Management, LLC$2.6B109,067,291+3.9%1.91%
Morgan Stanley$2.3B96,345,452+3.9%1.69%
Norges Bank$1.5B61,505,586+100.0%1.08%
Northern Trust Corp$1.4B59,084,573-4.7%1.04%
Bank Of New York Mellon Corp$1.4B57,879,546+7.4%1.02%
Massachusetts Financial Services Co$1.4B56,551,011-0.6%0.99%
State Farm Mutual Automobile Insurance Co$1.3B54,508,5600.0%0.96%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next PFE filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

5 filings of 390 on record
InsiderActionSharesPriceValueTrade dateDelay
Albert BourlaChairman & CEOBought38,000$26.34$1.0MAug 12, 20260d
Jennifer B. DamicoSVP & ControllerSold3,278$25.40$83KAug 5, 20261d
Mortimer J. BuckleyDirectorBought37,632$25.52$960KAug 5, 20260d
Ronald E. BlaylockDirectorBought39,231$25.46$999KAug 5, 20260d
Jennifer B. DamicoSVP & ControllerSold2,000$25.70$51KJun 9, 20261d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Congress trades in PFE

20 disclosures of 286 on record · median 28d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockPurchase$1,001 - $15,000+15.4%S&P +2.0% · vs S&P 500 +13.4%Jul 7, 2026Aug 7, 202631d
Michael A. RulliFiled lateStockSale$1,001 - $15,000+8.3%S&P +27.1% · vs S&P 500 -18.8%Nov 26, 2024Aug 7, 2026619d
Alan ArmstrongSelfFiled lateStockSale (Full)$50,001 - $100,000+3.0%S&P +16.4% · vs S&P 500 -13.3%Mar 24, 2026Jul 21, 2026119d
Tommy TubervilleJointStockSale (Full)$15,001 - $50,000+8.4%S&P +3.1% · vs S&P 500 +5.3%Jun 8, 2026Jul 16, 202638d
Ro KhannaStockSale$15,001 - $50,000+8.7%S&P +0.4% · vs S&P 500 +8.4%Jun 2, 2026Jul 6, 202634d
Ro KhannaStockSale$1,001 - $15,000+6.7%S&P +1.6% · vs S&P 500 +5.1%Jun 16, 2026Jul 6, 202620d
Ro KhannaStockPurchase$1,001 - $15,000+9.7%S&P +3.2% · vs S&P 500 +6.5%May 15, 2026Jun 9, 202625d
Ro KhannaStockPurchase$1,001 - $15,000+1.6%S&P +11.1% · vs S&P 500 -9.5%Apr 13, 2026May 11, 202628d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+4.5%S&P +15.1% · vs S&P 500 -10.5%Mar 13, 2026Apr 7, 202625d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+0.6%S&P +10.1% · vs S&P 500 -9.5%Feb 10, 2026Mar 9, 202627d
Ro KhannaStockSale$1,001 - $15,000+6.4%S&P +10.6% · vs S&P 500 -4.2%Jan 22, 2026Feb 6, 202615d
J. French HillStockSale$100,001 - $250,000+11.6%S&P +11.8% · vs S&P 500 -0.2%Dec 31, 2025Jan 23, 202623d
Julia LetlowFiled lateStockPurchase$1,001 - $15,000+16.3%S&P +27.8% · vs S&P 500 -11.5%Jun 17, 2025Jan 13, 2026210d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+10.3%S&P +11.7% · vs S&P 500 -1.4%Dec 19, 2025Jan 12, 202624d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+9.2%S&P +15.5% · vs S&P 500 -6.3%Nov 18, 2025Dec 15, 202527d
Ro KhannaStockSale$1,001 - $15,000+15.9%S&P +15.4% · vs S&P 500 +0.5%Sep 15, 2025Oct 3, 202518d
Ro KhannaStockSale$1,001 - $15,000+11.7%S&P +17.8% · vs S&P 500 -6.1%Sep 5, 2025Oct 3, 202528d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+18.6%S&P +21.0% · vs S&P 500 -2.4%Aug 4, 2025Sep 12, 202539d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+12.2%S&P +21.4% · vs S&P 500 -9.1%Aug 5, 2025Sep 12, 202538d
Ro KhannaStockPurchase$1,001 - $15,000+18.1%S&P +20.8% · vs S&P 500 -2.7%Aug 4, 2025Sep 9, 202536d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

20 members · estimate, as of Sep 10, 2026

20 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Harriet M. HagemanRepublican · House$15,001 - $50,0001.4%
Laurel M. LeeRepublican · House$15,001 - $50,0000.7%
Debbie DingellDemocrat · House$15,001 - $50,0000.5%
Laura FriedmanDemocrat · House$15,001 - $50,0007.2%
Ralph NormanRepublican · House$15,001 - $50,0002.1%
Robert BresnahanRepublican · House$15,001 - $50,0000.3%
Robert OnderRepublican · House$15,001 - $50,0000.7%
Jacky RosenDemocrat · Senate$15,001 - $50,0000.6%
Tommy TubervilleRepublican · Senate$15,001 - $50,0001.0%
Daniel MeuserRepublican · House$15,001 - $50,0001.1%
Cliff BentzRepublican · House$15,001 - $50,0001.2%
Randy FineRepublican · House$15,001 - $50,0000.9%
Andy BarrRepublican · House$1,001 - $15,0001.8%
Glenn IveyDemocrat · House$1,001 - $15,0001.4%
Julia LetlowRepublican · House$1,001 - $15,0000.8%
Katherine M. ClarkDemocrat · House$1,001 - $15,0000.1%
Robert B. AderholtRepublican · House$1,001 - $15,0001.1%
Gilbert Ray Cisneros, Jr.Democrat · House$1,001 - $15,000<0.1%
Gary C. PetersDemocrat · Senate$1,001 - $15,0000.2%
Shelley Moore CapitoRepublican · Senate$1,001 - $15,0000.3%

A further 1 member reports a position estimated under $1,000; those are not listed.

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Awards, option exercises and gifts (20)
InsiderEventSharesDate
Albert BourlaChairman & CEOStock award21Aug 31, 2026
Albert BourlaChairman & CEOStock award22Aug 14, 2026
Albert BourlaChairman & CEOStock award24Jul 31, 2026
Albert BourlaChairman & CEOStock award24Jul 15, 2026
Albert BourlaChairman & CEOStock award84Jul 9, 2026
Albert BourlaChairman & CEOStock award25Jun 30, 2026
Joseph EchevarriaDirectorStock award3,808Jun 26, 2026
Cyrus TaraporevalaDirectorStock award3,088Jun 26, 2026
James QuinceyDirectorStock award3,191Jun 26, 2026
James C. SmithDirectorStock award3,705Jun 26, 2026
Mortimer J. BuckleyDirectorStock award3,088Jun 26, 2026
Shantanu NarayenDirectorStock award4,117Jun 26, 2026
Albert BourlaChairman & CEOStock award23Jun 15, 2026
Albert BourlaChairman & CEOStock award23May 29, 2026
Albert BourlaChairman & CEOStock award24May 15, 2026
Albert BourlaChairman & CEOStock award22Apr 30, 2026
Joseph EchevarriaDirectorStock award15,373Apr 23, 2026
Susan Desmond-HellmannDirectorStock award15,373Apr 23, 2026
Ronald E. BlaylockDirectorStock award15,373Apr 23, 2026
James C. SmithDirectorStock award15,373Apr 23, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling PFE?

Across the 5 most recent open-market filings shown here, 3 were purchases and 2 were sales.

Which members of Congress have traded PFE?

Ro Khanna, Michael A. Rulli, Alan Armstrong, Tommy Tuberville, Gilbert Ray Cisneros, Jr., J. French Hill and others disclosed PFE transactions in the filings shown here.

Which members of Congress hold PFE?

20 members of Congress report a position in PFE in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Harriet M. Hageman, Laurel M. Lee and Debbie Dingell. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is PFE in the S&P 500 or the Nasdaq 100?

Pfizer Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.

How quickly are PFE trades disclosed?

Insider filings on this page reached the public a median of 0 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track